Enterofuril caps. 200mg # 16

Release form, composition and packaging

?

Hard gelatin capsules, size No. 0, opaque, brown

the contents of the capsules are yellow powder or yellow powder with inclusions in the form of small pieces of compressed mass, or compressed yellow powder, which crumbles when lightly pressed.

1 caps.

nifuroxazide 200 mg

sucrose - 68 mg, corn starch - 65.9 mg, microcrystalline cellulose - 9 mg, magnesium stearate - 7.1 mg.

The composition of the capsule shell: titanium dioxide (E171) - 2.95%, iron dye yellow oxide (E172) - 1%, gelatin - qs up to 100%.

8 pcs.

- blisters (2) - cardboard packs.

8 pcs.

- blisters (4) - cardboard packs.

pharmachologic effect

Broad-spectrum antimicrobial drug derived from 5-nitrofuran. Blocks the activity of dehydrogenases and inhibits the respiratory chain, the tricarboxylic acid cycle and a number of other biochemical processes in the microbial cell. Destroys the membrane of a microbial cell, reduces the production of toxins by microorganisms. Highly active against Campylobacter jejuni, Escherichia coli, Salmonella spp., Clostridium perfringens, Vibrio cholerae, pathogenic Vibrions and Vibrio parahaemolyticus, Staphylococcus spp. Weakly sensitive to nifuroxazide: Klebsiella spp., Proteus mirabilis, Providencia indologenes. Resistant to nifuroxazide: Klebsiella spp., Proteus mirabilis, Providencia spp., Pdeudomonas spp. Does not disturb the balance of intestinal microflora. In case of acute bacterial diarrhea, it restores intestinal eubiosis.When infected with enterotropic viruses, it prevents the development of bacterial superinfection.

Pharmacokinetics

After oral administration, nifuroxazide is practically not absorbed from the digestive tract and exhibits its antibacterial effect exclusively in the intestinal lumen.

Nifuroxazide is excreted by the intestines.

Indications for use

- acute bacterial diarrhea, proceeding without deterioration of the general condition, fever, intoxication.

Contraindications for use

- hypersensitivity to drug components or other nitrofuran derivatives

- fructose intolerance

- syndrome of glucose-galactose malabsorption or deficiency of sucrase and isomaltase

- pregnancy

- age up to 1 month, premature newborns (oral suspension)

- children under 3 years of age (capsules).

Dosage regimen

Is taken internally. Capsules 100 mg Adults and children over 7 years old: 2 capsules 4 times / day (200 mg 4 times / day). The daily dose is 800 mg. Children aged 3 to 7 years: 2 capsules 3 times / day (200 mg 3 times / day). The daily dose is 600 mg. Capsules 200 mg Adults and children over 7 years old: 1 capsule 4 times / day (200 mg 4 times / day). The daily dose is 800 mg. Children aged 3 to 7 years: 1 capsule 3 times / day (200 mg 3 times / day). The daily dose is 600 mg. Suspension for oral administration For dosing, a 5 ml measuring spoon with a graduation of 2.5 ml is used. Shake the suspension well before use. Children aged 1 to 6 months: 2.5 ml of the suspension 2-3 times / day with an interval of 8 to 12 hours. Children from 7 months to 3 years: 2.5 ml of the suspension 3 times / day with an interval of 8 hours. 3 to 6 years old:5 ml of suspension 3 times / day with an interval of 8 hours.Children aged 6 to 18 years: 5 ml of suspension 3-4 times a day with an interval of 6 to 8 hours. Adults: 5 ml of suspension 4 times / day with an interval of 6 hours. The duration of the course of treatment is 5-7 days, but not more than 7 days. If there is no improvement within the first 3 days of taking, you should consult a doctor.

Overdose

Overdose symptoms are unknown.

Treatment is symptomatic.

Side effect

Allergic reactions: rash, urticaria, Quincke's edema, anaphylactic shock.

Drug interactions

Simultaneous use with drugs that cause the development of disulfiram-like reactions, medicinal preparations is not recommended

Name ENG

ENTEROFURYL

Clinical and pharmacological group

Intestinal antiseptic.

Antidiarrheal drug

ATX code

Nifuroxazide

Dosage

200mg

Structure

1 capsule contains: active ingredient: nifuroxazide 200 mg.

excipients: sucrose - 71 mg

corn starch - 68 mg

MCC - 9 mg

magnesium stearate - 2 mg.

shell: gelatin

titanium dioxide

dye iron oxide yellow.

Indications

Diarrhea of ​​bacterial origin.

INN / Active ingredient

nifuroxazide

Storage conditions and periods

At a temperature not higher than 30 degrees.

Expiration date: 5 years

Contraindications

Hypersensitivity to nitrofuran derivatives or other components of the drug

fructose intolerance, glucose-galactose malabsorption syndrome or sucrase and isomaltase deficiency.

children under 3 years old.

Specifications

Category

Diarrhea

Scope of the drug

Gastrointestinal tract

Release form

Capsules

Manufacturer country

Bosnia and Herzegovina

Package quantity, pcs

16

Scope of application

Gastroenterology

Minimum age from

3 years old

Vacation conditions

Without recipe

Brand name

Bosnalek +

The amount of the dosage form in the primary package

8 pcs.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Antimicrobial agent - nitrofuran

Anatomical and therapeutic characteristics

A07AX03 Nifuroxazide

Dosage form

Capsules

Dosage (volume) of the substance in the preparation

nifuroxazide 200 mg

Expiration date in days

1095

Package weight, g

thirty

Mode of application

:

Inside.

Nifuroxazide therapy should not be continued for more than 7 days.

< br> For adults and children over 7 years old, the drug is prescribed 1 capsule (200 mg) 4 times a day, the daily dose is 800 mg.

< br> For children 3–7 years old, the drug is prescribed 1 capsule (200 mg) 3 times a day, the daily dose is 600 mg.

Information on technical characteristics, delivery set, country of manufacture